课题基金 / 基金详情

Identification of a low molecular weight peptide of CD109 as an anti-scarring agent

Identification of a low molecular weight peptide of CD109 as an anti-scarring agent
CD109 低分子量肽作为抗疤痕剂的鉴定
批准号：
196281
负责人：
Philip Anie
金额：
$10.93万
依托单位：
Montreal General Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2009
资助国家：
加拿大
项目状态：
已结题
起止时间：
2009-10-01 至 2010-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=196281&lang=en
关键词：
Cd109 Scarring Tgf-Beta Wound Healing

项目摘要

项目成果

Philip Anie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Wound healing is a normal response to tissue injury and involves many growth factors that control cell growth, movement (migration) and production of the extracellular matrix (ECM) that provides structural support to the repairing tissue. Transforming gro
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a novel anti-fibrotic peptide for the treatment of scleroderma
Role of CD109 in regulating cellular signaling and responses in skin and oral squamous cell carcinoma cells
Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
海外基金